Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease.

Casas J, Friedman DF, Jackson T, Vege S, Westhoff CM, Chou ST.

Transfusion. 2015 Jun;55(6 Pt 2):1388-93. doi: 10.1111/trf.12987. Epub 2015 Jan 9.

PMID:
25573464
2.

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).

Lasalle-Williams M, Nuss R, Le T, Cole L, Hassell K, Murphy JR, Ambruso DR.

Transfusion. 2011 Aug;51(8):1732-9. doi: 10.1111/j.1537-2995.2010.03045.x. Epub 2011 Feb 18.

PMID:
21332724
3.

Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Karafin MS, Field JJ, Gottschall JL, Denomme GA.

Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9.

PMID:
25757390
4.

Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.

Wilkinson K, Harris S, Gaur P, Haile A, Armour R, Teramura G, Delaney M.

Transfusion. 2012 Feb;52(2):381-8. doi: 10.1111/j.1537-2995.2011.03288.x. Epub 2011 Aug 9.

PMID:
21827505
5.

DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.

Castilho L, Rios M, Bianco C, Pellegrino J Jr, Alberto FL, Saad ST, Costa FF.

Transfusion. 2002 Feb;42(2):232-8.

PMID:
11896340
6.

Alloimmunization in sickle cell anemia in the era of extended red cell typing.

O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.

Pediatr Blood Cancer. 2013 Sep;60(9):1487-91. doi: 10.1002/pbc.24530. Epub 2013 Mar 18.

PMID:
23508932
7.

Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C.

Blood Cells Mol Dis. 2014 Apr;52(4):195-202. doi: 10.1016/j.bcmd.2013.11.003. Epub 2013 Dec 2.

8.

Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.

Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM.

Transfusion. 2017 Nov;57(11):2738-2746. doi: 10.1111/trf.14282. Epub 2017 Aug 24.

9.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.

Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.

Transfusion. 2002 Jan;42(1):37-43. Review.

PMID:
11896310
10.

Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.

Fasano RM, Chou ST.

Transfus Med Rev. 2016 Oct;30(4):197-201. doi: 10.1016/j.tmrv.2016.05.011. Epub 2016 May 28. Review.

PMID:
27345938
11.

Red blood cell alloimmunization in sickle cell disease patients in Uganda.

Natukunda B, Schonewille H, Ndugwa C, Brand A.

Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x. Epub 2009 Oct 10.

PMID:
19821949
12.

Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.

McPherson ME, Anderson AR, Haight AE, Jessup P, Castillejo MI, Hillyer CD, Josephson CD.

Transfusion. 2009 Sep;49(9):1977-86. doi: 10.1111/j.1537-2995.2009.02213.x. Epub 2009 May 11.

PMID:
19453984
13.
14.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM.

Blood. 2013 Aug 8;122(6):1062-71. doi: 10.1182/blood-2013-03-490623. Epub 2013 May 30.

15.

DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.

Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J Jr, Castilho L.

Vox Sang. 2009 Aug;97(2):147-52. doi: 10.1111/j.1423-0410.2009.01185.x. Epub 2009 Apr 8.

PMID:
19392786
16.

Noninvasive buccal swab antigen sample and molecular testing provides extended antigen typing for patients with hemoglobinopathies.

Rampersad A, Hampton K, Duncan N, Roberson C, Slayten J, Davisson S, Aronowitz J, Shapiro A.

J Pediatr. 2014 Nov;165(5):1003-7. doi: 10.1016/j.jpeds.2014.07.059. Epub 2014 Sep 11.

PMID:
25217842
17.

Routine non-ABO blood group antigen genotyping in sickle cell disease: the new frontier in pretransfusion testing?

Tormey CA, Hendrickson JE.

Transfusion. 2015 Jun;55(6 Pt 2):1374-7. doi: 10.1111/trf.13065. No abstract available.

PMID:
26094720
18.

The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients.

Makarovska-Bojadzieva T, Velkova E, Blagoevska M.

Open Access Maced J Med Sci. 2017 Apr 8;5(2):107-111. doi: 10.3889/oamjms.2017.054. eCollection 2017 Apr 15.

19.

High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform.

Hopp K, Weber K, Bellissimo D, Johnson ST, Pietz B.

Transfusion. 2010 Jan;50(1):40-6. doi: 10.1111/j.1537-2995.2009.02377.x. Epub 2009 Sep 16.

PMID:
19761548
20.

Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.

Ameen R, Al Shemmari S, Al-Bashir A.

Transfusion. 2009 Aug;49(8):1649-54. doi: 10.1111/j.1537-2995.2009.02185.x.

PMID:
19453992

Supplemental Content

Support Center